Netherlands?page=3 Latest Articles
Life Sciences and Healthcare
EU revised device rules rebalance compliance towards simplification and proportionality
Commission proposal would streamline MDR and IVDR duties with flexible evidence, timeless certificates and tailored risk rules
New
-
09/01/2026
Read time
9m
Intellectual property
Looking forward: what is on the agenda for European patent litigation in 2026?
European courts' long-arm jurisdiction and escalating comity tensions in SEP licensing disputes will be at the forefront, alongside sweeping EU pharmaceutical reforms
New
-
09/01/2026
Read time
12m
ESG – Environmental, social and governance
ESG Knowledge Update | December 2025
Welcome to our Osborne Clarke ESG Knowledge Update, which offers a round-up of legal, regulatory and market news
22/12/2025
Read time
6m
Life Sciences and Healthcare
European Parliament and Council provisional deal on new genomic techniques brings relaxation of gene editing a step closer
Two-tier categorisation of NGT plants endorsed alongside a patent ban rowback but patent transparency measures agreed
16/12/2025
Read time
5m
